October 1964
Volume 3, Issue 5
Articles  |   October 1964
Symposium on Therapy: Complications and Management
Author Affiliations
    Department of Ophthalmology, University of Minnesota Medical School, Minneapolis, Minn.
Investigative Ophthalmology & Visual Science October 1964, Vol.3, 481-488. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JOHN E. HARRIS; Symposium on Therapy: Complications and Management . Invest. Ophthalmol. Vis. Sci. 1964;3(5):481-488.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements
This content is PDF only. Please click on the PDF icon to access.

Of the large number of drugs which come under the classification of cardiovascular renal agents, only a few, the carbonic anhydrase inhibitors and the osmotic diuretics, have general usefulness in ophthalmic practice. However, a good portion of the patients the ophthalmologist may be treating may be taking other cardiovascular renal drugs for other physical ailments. The drugs of this group most likely to be encountered are the antiarterial hypertensives, the cardiac glycosides, and the various diuretics. Ophthalmologists must recognize the mode of action and side effects of these drugs, and the added toxicity which may be induced by the therapy which he applies.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.